Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. - Bataller A; Gener-Ricos G; Almanza-Huante E; Chien KS; Urrutia S; Bazinet A; Rodriguez-Sevilla JJ; Hammond D; Sasaki K; Takahashi K; DiNardo CD; Ravandi F; et al. (Blood advances, 2024)